Balaji Amines reported FY26 consolidated revenue of ₹1,424.98 crore and PAT of ₹169.16 crore. The company declared a dividend of ₹11 per share. This marks a turnaround after two years of subdued chemical pricing.

Balaji Amines Reports FY26 Results, Dividend Declared

Consolidated Revenue: ₹1,424.98 crore
Consolidated PAT: ₹169.16 crore

Reader Takeaway: Debt-free growth and import substitution drive performance amid market challenges.

What just happened

Balaji Amines announced its financial results for FY26, reporting a consolidated revenue of ₹1,424.98 crore and a consolidated Profit After Tax (PAT) of ₹169.16 crore. The company also declared a dividend of ₹11 per share. On a standalone basis, revenue stood at ₹1,291.54 crore with PAT at ₹165.53 crore.

Why this matters

These results indicate a potential turning point for Balaji Amines after two challenging years marked by low global chemical prices. The company's performance highlights its ability to improve profitability even in a difficult market, supported by strategic operational milestones and expansion plans.

The backstory

The company has navigated a period of subdued global chemical pricing. Its standalone operations continue to maintain a debt-free status, with expansion projects funded entirely through internal accruals, underscoring financial prudence.

What changes now

FY26 saw the company achieve key operational goals, including the full year of operations for its methylamines plant, the commissioning of the MIPA plant, and the launch of India's first electronic-grade Dimethyl Carbonate (DMC) plant. An expansion worth ₹750 crore is underway at Balaji Speciality Chemicals Limited (BSCL), which has received 'Mega Project' status.

Risks to watch

Global economic uncertainties, geopolitical tensions, and trade volatility could affect demand and raw material costs. Reliance on imported feedstocks poses a risk to margins and supply chain stability. Investors will be watching the timely ramp-up of the BSCL mega project.

Peer comparison

Balaji Amines operates in the speciality chemicals sector, which has faced cyclical downturns. The company's focus on import substitution and entering high-growth areas like EV batteries differentiates its strategy.

Context metrics (time-bound)

Consolidated Revenue for FY26 was ₹1,424.98 crore, a slight increase from ₹1,397.08 crore in FY25. Consolidated PAT rose to ₹169.16 crore in FY26 from ₹158.59 crore in FY25.

What to track next

Management has guided for 10–15% consolidated volume growth in FY27, with EBITDA margins expected between 22–23%. In the medium term, a 20–30% volume growth is projected as new units, including those at BSCL, increase production. Investors should monitor the execution of the BSCL expansion and margin stability.